EssilorLuxottica and Aravind Eye Hospital Launch Myopia Excellence Centre in Chennai to Combat Myopia in Children
Chennai, July 26, 2023: EssilorLuxottica, global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, and Aravind Eye Hospital a prominent network of eye hospitals committed to exceptional patient care, are pleased to announce the launch of the Myopia Excellence Centre in Chennai, India. The Myopia Excellence Centre aims to address the growing concerns surrounding myopia and revolutionize its management amongst affected children.
The prevalence of myopia continues to rise at an alarming rate, and projections indicate that 50% of the world’s population will be myopic by 2050. Leveraging the efficiency of Stellest, the Myopia Excellence Centre created by EssilorLuxottica and Aravind Eye Hospital aims to revolutionize the early detection and treatment of myopia in children, by integrating cutting-edge lens technologies with the highest standard of patient care. Unlike conventional setups, this specialized facility is designed to provide a holistic approach to pediatric myopia management, incorporating various essential components under one roof.
Narasimhan Narayanan, Country Head, EssilorLuxottica South Asia, says, “With the world facing a myopia epidemic, early detection and intervention are paramount. Through our Myopia Excellence Centre, we aim to create a standardized and patient-centric environment to ensure that children with myopia receive the best care possible. We have created this space to make myopia management seamless and comfortable for parents and their little ones – through the Centre, Aravind Hospital will prescribe the best myopia control solution available via Stellest. EssilorLuxottica is committed to leverage its 30 years track record in myopia management to push the boundaries of vision technology and contribute to improve the lives of children affected by myopia.”
We are taking a significant step forward in combating the growing myopia epidemic, said Dr. Aravind, Chief Medical Officer, Aravind Eye Hospital “With the increasing prevalence of myopia, it is crucial for us to take a proactive approach in addressing this public health issue. Our vision for the Myopia Excellence Center is to provide our young patients with advanced, evidence-based treatments.”
The Myopia Excellence Center will be will be supported by a team of renowned ophthalmologists and optometrists dedicated to myopia management via detection, education, counselling, dispensing and follow up. This multidisciplinary team will collaborate closely with patients to provide tailored treatment plans, monitor myopia progression, and offer innovative solutions to slow down its advancement. The center will also play a crucial role in advancing myopia research, publication of scientific papers, and collaboration with leading academic institutions and industry partners.
The collaboration between EssilorLuxottica and the Aravind Hospital is a significant step towards battling the global myopia crisis, offering expert care, best-in-class technologies, education, and counselling to empower parents as well as pave the way for a brighter and clearer future for the world’s young generation.
About EssilorLuxottica
EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, its mission is to help people around the world to see more and be more by addressing their evolving vision needs and personal style aspirations. The Company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craftsmanship of iconic eyewear, to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley, lens technology brands including Varilux and Transitions, and world-class retail brands including Sunglass Hut, LensCrafters, Salmoiraghi & Viganò and GrandVision are part of the EssilorLuxottica family. EssilorLuxottica has approximately 190,000 employees. In 2022, the Company generated consolidated revenue of Euro 24.5 billion. The EssilorLuxottica share trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESLX.PA; Bloomberg: EL:FP. For more information, please visit www.essilorluxottica.com.
NS
For more information, contact:
Deepika Maheshwari
+91 97605 73262
Palak Garodia
+91 70760 46448